In vitro fertilization (IVF) is a procedure that involves collecting eggs from the ovaries, fertilizing them with sperm outside the womb, and transferring them into the uterus as embryos. It supports conception when individuals are unable to become pregnant naturally; this may be due to issues such as ovulation disorders or unexplained infertility. When an IVF cycle does not result in pregnancy, additional testing is often needed. ReceptivaDx helps detect conditions that can lead to issues and prevent implantation. Here are several ways to navigate issues with IVF failure:
Review the Treatment Plan
IVF treatment plans are personalized medical strategies designed to help achieve pregnancy; they involve various coordinated steps, from egg retrieval to embryo transfer. Each phase is carefully timed and adjusted based on individual response. This helps optimize the chances of fertilization, healthy embryo development, and successful implantation. Success rates vary widely depending on several factors, including age. Approximately 41 to 43% of women under the age of 35 experience a live birth using this treatment method. If IVF failure does occur, there may be several possible causes, including:
- Embryo quality and genetics
- Uterine factors
- Endometrial receptivity
- Hormonal support
- Inflammation or immune-related factors
Even when embryos appear healthy, chromosomal abnormalities can prevent implantation and lead to IVF failure. Uterine factors include structural issues such as fibroids, polyps, or adhesions. Subtle abnormalities in the uterine lining can also interfere with embryo attachment. Endometrial receptivity focuses on whether the uterus is properly prepared and synchronized with embryo transfer timing; even slight misalignments have the potential to affect implantation success.
Hormonal support is also key for maintaining a receptive uterine environment. Inadequate levels can reduce the chances of implantation. If no clear cause is identified, doctors are able to explore whether underlying inflammation is affecting implantation. Some inflammation-causing conditions are not clearly visible with imaging, but they may be identified using targeted testing.
Complete Additional Testing
Underlying health conditions have a significant impact on the outcome of IVF, and targeted testing helps identify potential issues. ReceptivaDx can detect several diseases with a single biopsy. It tests for elevated levels of BCL6, which is associated with chronic inflammation in the uterine lining and is commonly linked to endometriosis.
Endometriosis
Endometriosis occurs when tissue that is similar to the uterine lining grows outside the uterus; this can lead to inflammation, hormonal disruption, and scarring. Even when it is asymptomatic, it sometimes affects implantation by altering the uterine environment. In some cases, this condition also contributes to progesterone resistance or reduced endometrial receptivity. Identifying and treating underlying endometriosis before another IVF attempt may improve the likelihood of successful implantation and pregnancy outcomes.
Progesterone Resistance
Progesterone resistance occurs when the uterine lining does not respond properly to progesterone; this hormone prepares the endometrium for implantation. Even when progesterone levels in the blood appear adequate, the uterine lining may not respond as expected. This sometimes leads to implantation failure or early pregnancy loss.
Resistance may occur alongside chronic inflammation and conditions like endometriosis. There are different management options, and these include adjusting progesterone dosing or changing delivery methods. Addressing underlying inflammation before proceeding with another embryo transfer can also improve endometrial receptivity.
Endometritis
Endometritis is another condition that affects IVF outcomes by causing inflammation of the uterine lining. Unlike endometriosis, this condition results from a chronic bacterial infection. The ReceptivaDx test helps detect endometritis by measuring the CD138 marker. Treatment may involve targeted antibiotic therapy, and it is sometimes followed by repeat testing to confirm that the infection or inflammation has resolved.
Treat Underlying Conditions
If additional testing detects elevated levels of BCL6, individuals can work with a specialist to address the underlying cause before attempting another IVF cycle. An official endometriosis diagnosis is confirmed with laparoscopic surgery. This procedure allows a physician to visualize the pelvic organs; they may also remove or treat endometriosis lesions at the same time.
After diagnosis, treatment typically focuses on reducing inflammation and improving uterine receptivity before the next embryo transfer. This may include temporary hormonal suppression with medications such as GnRH agonists. These medications help reduce endometriosis activity; they create a more favorable environment for implantation. After treatment, clinicians may reassess the IVF plan, including progesterone support and transfer timing. This aims to optimize the chances of success in future cycles.
Learn More About IVF Failure
Navigating IVF failure involves reviewing each stage of treatment to identify potential areas for adjustment. Clinicians can assess embryo quality and hormonal support, as well as investigate underlying factors such as inflammation. Additional testing helps detect issues like endometriosis, and it allows individuals to pursue treatment before beginning another IVF cycle. ReceptivaDx narrows down potential next steps, enabling patients to detect and treat hidden endometriosis to promote better outcomes. Talk to your doctor today to learn more.
